Amlodipine Besylate Tablet
Product Images NDC 71610-928

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71610-928). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0928 30)

A prescription drug label for Amlodipine Besylate, USP 10 mg oral tablets. The label indicates a package of 30 tablets and includes storage instructions to keep the drug between 20-25 degrees Celsius and out of reach of children. The product is manufactured by CipherPharma, LLC in Middlesex, NJ, and repackaged by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. The NDC number shown is 71610-928-30.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemstruc (Chemstruc)

Chemical structure diagram of amlodipine besylate, showing the molecular framework with labeled atoms and functional groups, along with the molecular formula C6H6O3S displayed below the structure.*

FDA Label Image

Fig1 (Fig1)

A Kaplan-Meier survival curve chart depicting event rates over 24 months comparing Amlodipine and Placebo. The X-axis represents time in months, and the Y-axis shows the event rate. The chart includes a P-value of 0.003, hazard ratio of 0.691, and 95% confidence interval from 0.54 to 0.88. Numbers at risk are displayed below the X-axis.*

FDA Label Image

Fig2 (Fig2)

A forest plot chart showing hazard ratios with 95% confidence intervals, comparing Amlodipine Besylate to placebo across patient subgroups defined by age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The horizontal axis ranges from 0.0 to 2.0 hazard ratio, with labels indicating which side favors Amlodipine or placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.